Skip to content
healthcare.dev

Ganirelix Acetate

NDC 67184-0574, Ganirelix Acetate, injection, solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0574
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218855
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0574 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GANIRELIX ACETATE250 ug/.5mL

Pharmacologic classes

Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]

Package NDCNDC-11Package
67184-0574-1671840574011 BLISTER PACK in 1 CARTON (67184-0574-1) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/440f6d67-f02e-4407-8830-39c394e25e5d

Use it

Look up 67184-0574 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0574 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0574. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.